54 related articles for article (PubMed ID: 19437927)
21. Impact of the Pregnancy and Lactation Labeling Rule (PLLR) on Practicing Dermatologists.
Beroukhim K; Abrouk M; Farahnik B
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632938
[TBL] [Abstract][Full Text] [Related]
22. Categorizing the safety of medications during pregnancy and lactation.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2009 Apr; 47(4):17-20. PubMed ID: 19437927
[TBL] [Abstract][Full Text] [Related]
23. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
Brucker MC; King TL
J Midwifery Womens Health; 2017 May; 62(3):308-316. PubMed ID: 28556499
[TBL] [Abstract][Full Text] [Related]
24. Recent changes in pregnancy and lactation labeling: retirement of risk categories.
Ramoz LL; Patel-Shori NM
Pharmacotherapy; 2014; 34(4):389-95. PubMed ID: 24390829
[TBL] [Abstract][Full Text] [Related]
25. Drug safety: Pregnancy rating classifications and controversies.
Wilmer E; Chai S; Kroumpouzos G
Clin Dermatol; 2016; 34(3):401-9. PubMed ID: 27265079
[TBL] [Abstract][Full Text] [Related]
26. Medications in pregnancy and lactation.
McCarter-Spaulding DE
MCN Am J Matern Child Nurs; 2005; 30(1):10-7; quiz 18-9. PubMed ID: 15622140
[TBL] [Abstract][Full Text] [Related]
27. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy.
Murase JE; Heller MM; Butler DC
J Am Acad Dermatol; 2014 Mar; 70(3):401.e1-14; quiz 415. PubMed ID: 24528911
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the safety of medications during pregnancy and lactation.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2009 Mar; 47(3):19-22. PubMed ID: 19361010
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease.
Saha S; Wald A
Expert Opin Drug Saf; 2012 Nov; 11(6):947-57. PubMed ID: 22954378
[TBL] [Abstract][Full Text] [Related]
30. Availability of Safe and Effective Therapeutic Options to Pregnant and Lactating Individuals Following the United States Food and Drug Administration Pregnancy and Lactation Labeling Rule.
Patel A; Sushko K; Mazer-Amirshahi M; Pfuma Fletcher E; Fusch G; Chan O; Aghayi A; Chan AKC; Lacaze-Masmonteil T; Van Den Anker J; Samiee-Zafarghandy S
J Pediatr; 2023 Aug; 259():113342. PubMed ID: 36806753
[TBL] [Abstract][Full Text] [Related]
31. Guide for Drug Selection During Pregnancy and Lactation: What Pharmacists Need to Know for Current Practice.
Griffin BL; Stone RH; El-Ibiary SY; Westberg S; Shealy K; Forinash A; Yancey A; Vest K; Karaoui LR; Rafie S; Horlen C; Lodise N; Cieri-Hutcherson N; McBane S; Simonyan A
Ann Pharmacother; 2018 Aug; 52(8):810-818. PubMed ID: 29519141
[TBL] [Abstract][Full Text] [Related]
32. Black-Box Warnings of Antiseizure Medications: What is Inside the Box?
Wahab A; Iqbal A
Pharmaceut Med; 2023 May; 37(3):233-250. PubMed ID: 37119452
[TBL] [Abstract][Full Text] [Related]
33. Prescribing for the pregnant patient.
Mehta N; Chen K; Powrie RO
Cleve Clin J Med; 2014 Jun; 81(6):367-72. PubMed ID: 24891538
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary.
Wang J; Johnson T; Sahin L; Tassinari MS; Anderson PO; Baker TE; Bucci-Rechtweg C; Burckart GJ; Chambers CD; Hale TW; Johnson-Lyles D; Nelson RM; Nguyen C; Pica-Branco D; Ren Z; Sachs H; Sauberan J; Zajicek A; Ito S; Yao LP
Clin Pharmacol Ther; 2017 Jun; 101(6):736-744. PubMed ID: 28510297
[TBL] [Abstract][Full Text] [Related]
35. Glaucoma in pregnancy.
Salim S
Curr Opin Ophthalmol; 2014 Mar; 25(2):93-7. PubMed ID: 24469077
[TBL] [Abstract][Full Text] [Related]
36. Drugs during pregnancy: an issue of risk classification and information to prescribers.
Sannerstedt R; Lundborg P; Danielsson BR; Kihlström I; Alván G; Prame B; Ridley E
Drug Saf; 1996 Feb; 14(2):69-77. PubMed ID: 8852521
[TBL] [Abstract][Full Text] [Related]
37. The new FDA labeling rule: impact on prescribing rheumatological medications during pregnancy.
Bermas BL; Tassinari M; Clowse M; Chakravarty E
Rheumatology (Oxford); 2018 Jul; 57(suppl_5):v2-v8. PubMed ID: 30137587
[TBL] [Abstract][Full Text] [Related]
38. Drugs in Lactation.
Anderson PO
Pharm Res; 2018 Feb; 35(3):45. PubMed ID: 29411152
[TBL] [Abstract][Full Text] [Related]
39. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2016 and 2017.
Barrow P
Reprod Toxicol; 2018 Sep; 80():117-125. PubMed ID: 29660390
[TBL] [Abstract][Full Text] [Related]
40. Physicians' liability for adverse drug reactions.
Kaufman MB; Stoukides CA; Campbell NA
South Med J; 1994 Aug; 87(8):780-4. PubMed ID: 8052883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
